The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors originating from chromaffin cells in the adrenal medulla (PCCs) or extra-adrenal sympathetic or parasympathetic paraganglia (PGLs). About 40% of PPGLs result from germline mutations and therefore they are highly inheritable....
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2020.586857/full |
_version_ | 1818240565298331648 |
---|---|
author | Song Peng Jun Zhang Xintao Tan Yiqiang Huang Jing Xu Natalie Silk Dianzheng Zhang Qiuli Liu Jun Jiang |
author_facet | Song Peng Jun Zhang Xintao Tan Yiqiang Huang Jing Xu Natalie Silk Dianzheng Zhang Qiuli Liu Jun Jiang |
author_sort | Song Peng |
collection | DOAJ |
description | Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors originating from chromaffin cells in the adrenal medulla (PCCs) or extra-adrenal sympathetic or parasympathetic paraganglia (PGLs). About 40% of PPGLs result from germline mutations and therefore they are highly inheritable. Although dysfunction of any one of a panel of more than 20 genes can lead to PPGLs, mutations in genes involved in the VHL/HIF axis including PHD, VHL, HIF-2A (EPAS1), and SDHx are more frequently found in PPGLs. Multiple lines of evidence indicate that pseudohypoxia plays a crucial role in the tumorigenesis of PPGLs, and therefore PPGLs are also known as metabolic diseases. However, the interplay between VHL/HIF-mediated pseudohypoxia and metabolic disorder in PPGLs cells is not well-defined. In this review, we will first discuss the VHL/HIF axis and genetic alterations in this axis. Then, we will dissect the underlying mechanisms in VHL/HIF axis-driven PPGL pathogenesis, with special attention paid to the interplay between the VHL/HIF axis and cancer cell metabolism. Finally, we will summarize the currently available compounds/drugs targeting this axis which could be potentially used as PPGLs treatment, as well as their underlying pharmacological mechanisms. The overall goal of this review is to better understand the role of VHL/HIF axis in PPGLs development, to establish more accurate tools in PPGLs diagnosis, and to pave the road toward efficacious therapeutics against metastatic PPGLs. |
first_indexed | 2024-12-12T13:15:28Z |
format | Article |
id | doaj.art-36897ea4881a47fba02686412f9ab1fe |
institution | Directory Open Access Journal |
issn | 1664-2392 |
language | English |
last_indexed | 2024-12-12T13:15:28Z |
publishDate | 2020-11-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj.art-36897ea4881a47fba02686412f9ab1fe2022-12-22T00:23:26ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922020-11-011110.3389/fendo.2020.586857586857The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/ParagangliomaSong Peng0Jun Zhang1Xintao Tan2Yiqiang Huang3Jing Xu4Natalie Silk5Dianzheng Zhang6Qiuli Liu7Jun Jiang8Department of Urology, Daping Hospital, Army Medical University, Chongqing, ChinaDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, ChinaDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, ChinaDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, ChinaDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, ChinaDepartment of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United StatesDepartment of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, PA, United StatesDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, ChinaDepartment of Urology, Daping Hospital, Army Medical University, Chongqing, ChinaPheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors originating from chromaffin cells in the adrenal medulla (PCCs) or extra-adrenal sympathetic or parasympathetic paraganglia (PGLs). About 40% of PPGLs result from germline mutations and therefore they are highly inheritable. Although dysfunction of any one of a panel of more than 20 genes can lead to PPGLs, mutations in genes involved in the VHL/HIF axis including PHD, VHL, HIF-2A (EPAS1), and SDHx are more frequently found in PPGLs. Multiple lines of evidence indicate that pseudohypoxia plays a crucial role in the tumorigenesis of PPGLs, and therefore PPGLs are also known as metabolic diseases. However, the interplay between VHL/HIF-mediated pseudohypoxia and metabolic disorder in PPGLs cells is not well-defined. In this review, we will first discuss the VHL/HIF axis and genetic alterations in this axis. Then, we will dissect the underlying mechanisms in VHL/HIF axis-driven PPGL pathogenesis, with special attention paid to the interplay between the VHL/HIF axis and cancer cell metabolism. Finally, we will summarize the currently available compounds/drugs targeting this axis which could be potentially used as PPGLs treatment, as well as their underlying pharmacological mechanisms. The overall goal of this review is to better understand the role of VHL/HIF axis in PPGLs development, to establish more accurate tools in PPGLs diagnosis, and to pave the road toward efficacious therapeutics against metastatic PPGLs.https://www.frontiersin.org/articles/10.3389/fendo.2020.586857/fullpheochromocytomasparagangliomasVHLHIFmetabolisminhibitor |
spellingShingle | Song Peng Jun Zhang Xintao Tan Yiqiang Huang Jing Xu Natalie Silk Dianzheng Zhang Qiuli Liu Jun Jiang The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma Frontiers in Endocrinology pheochromocytomas paragangliomas VHL HIF metabolism inhibitor |
title | The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma |
title_full | The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma |
title_fullStr | The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma |
title_full_unstemmed | The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma |
title_short | The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma |
title_sort | vhl hif axis in the development and treatment of pheochromocytoma paraganglioma |
topic | pheochromocytomas paragangliomas VHL HIF metabolism inhibitor |
url | https://www.frontiersin.org/articles/10.3389/fendo.2020.586857/full |
work_keys_str_mv | AT songpeng thevhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT junzhang thevhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT xintaotan thevhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT yiqianghuang thevhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT jingxu thevhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT nataliesilk thevhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT dianzhengzhang thevhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT qiuliliu thevhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT junjiang thevhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT songpeng vhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT junzhang vhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT xintaotan vhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT yiqianghuang vhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT jingxu vhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT nataliesilk vhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT dianzhengzhang vhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT qiuliliu vhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma AT junjiang vhlhifaxisinthedevelopmentandtreatmentofpheochromocytomaparaganglioma |